Technology Licensing opportunities

Available technologies

Clear search
Data-driven Multiplexing for Accurate Gene Detection

Machine learning approach for high-level multiplexing in qPCR and dPCR, up to 21-plex demonstrated

Artificial Golgi Reactor for Tailoring Glycans

A novel platform comprising immobilized enzymes to produce homogenously glycosylated proteins for therapeutic or diagnostic applications.

Ionic liquids with excipients as stabilisers for payloads in solution

Ionic liquid formulations that stabilise a range of payloads, antibodies and RNA-based systems, allowing pharmaceuticals to be storied in solution at room temperature.

Novel living ring-opening polymerisation method to synthesise a novel class of multifunctional, sequence-controlled, degradable and biocompatible polymers

A simple, scalable and cost-effective polymerisation method for synthesis of a class of novel, multifunctional, sequence-controlled, degradable and biocompatible polymers.

Bioharmonophores for biomedical precision imaging

Biodegradable, second-harmonic generating nanoprobes for targeted, high-resolution in vivo tumour imaging

SIMPLE: Single Incision Micro Ports for Laparoscopic Endo-surgery

A next generation surgical robotics platform for ultra-minimally invasive surgery via a single port, offering bimanual haptic control and enabling autonomous surgical tasks.

Circuit design for limiting Mycoplasma growth to bioreactors

Inducible systems developed for use in Mycoplasma species. These tools will contribute to the exploitation of Mycoplasma as a synthetic biology asset.

Dual DNA-PK/AKT inhibition for the treatment of platinum-resistant cancer

Novel compounds with dual DNA-PK/AKT inhibitor activity for the treatment of platinum-resistant cancers.

Use of valerate and bile salt hydrolase (BSH) as prevention and treatment for C. difficile infection

Use of short/medium chain fatty acids, including valerate and bile salt hydrolase (BSH) for the treatment and prevention of recurrent C. difficile infection

MicroRNA plasma markers for small-for-gestational-age (SGA) births

A set of microRNAs for predicting small-for-gestational-age (SGA) births based on the measurement of maternal blood samples taken in early pregnancy (gestation week 12 onwards).

Subscribe for Licensing Opportunities updates
Keep up to date with new technologies and licensing opportunities coming out of Imperial College London